阿拉斯加限制监狱中的类阿片治疗,与罗得岛不同的是,吸毒过量风险增加,因为罗德岛通过持续护理减少了死亡人数。 Alaska restricts opioid treatment in prisons, increasing overdose risk, unlike Rhode Island, which reduced deaths with consistent care.

阿拉斯加的监狱严重限制类阿片使用紊乱症获得药物辅助治疗的机会, Alaska’s prisons severely limit access to medication-assisted treatment for opioid use disorder, despite evidence that such care reduces overdose deaths and supports recovery. 治疗往往以阳性药物试验为基础而被拒绝——尽管药物试验造成这种结果——并且仅限于诸如怀孕或先前就已使用等狭隘情况。 Treatment is often denied based on positive drug tests—despite medication causing such results—and is restricted to narrow cases like pregnancy or pre-existing use. 专家们警告说,在监禁期间失去类阿片容忍度会增加释放时的剂量过量风险。 Experts warn that losing opioid tolerance during incarceration increases overdose risk upon release. 对比之下,罗得岛自2016年以来的全州计划将获释囚犯的超剂量死亡率削减了60%,这证明了持续、基于科学的护理的有效性。 In contrast, Rhode Island’s statewide program since 2016 cut overdose deaths among released inmates by 60%, proving the effectiveness of consistent, science-based care. 然而,阿拉斯加缺乏标准化政策,使获得治疗取决于工作人员的酌处权,未能满足关键的公共卫生需求。 Yet Alaska lacks standardized policy, leaving treatment access dependent on staff discretion and failing to address a critical public health need.